Medclair AB

Equities

MCLR

SE0009190572

Industrial Machinery & Equipment

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
1.195 ^SEK	-1.24%		+3.91%	-28.78%

2023	Medclair Invest AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Medclair Invest AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Medclair Invest AB Reports Earnings Results for the Half Year Ended June 30, 2021

August 18, 2021

Medclair Invest AB announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was SEK 1.173 million compared to SEK 104,000 a year ago. Net loss was SEK 5.958 million compared to SEK 849,000 a year ago.

Latest news about Medclair AB

Medclair Invest AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 01	CI
Medclair Invest AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-23	CI
Medclair Invest AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
Medclair Invest AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-21	CI
Medclair Invest AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-02	CI
Medclair Invest AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-10	CI
Medclair Invest AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-04	CI
Medclair Invest AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-22	CI
Medclair Invest AB Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-18	CI
Medclair Invest AB cancelled the acquisition of NoseOption AB.	21-03-31	CI
Medclair Invest AB agreed to acquire NoseOption AB for SEK 48.8 million.	21-03-22	CI
MedClair International AB completed the acquisition of Spintso International AB in a reverse merger transaction.	20-10-21	CI
MedClair International AB agreed to acquire Spintso International AB in a reverse merger transaction for SEK 20 million.	20-08-18	CI
MedClair AB completed the acquisition of US Energy Group AB (XSAT:USE B) from Anders Lagerberg and other shareholders in a reverse merger transaction.	16-09-04	CI
MedClair AB agreed to acquire US Energy Group AB (XSAT:USE B) from Anders Lagerberg and other shareholders in a reverse merger transaction.	16-05-25	CI

Chart Medclair AB

Duration

Period

More charts

Company Profile

Medclair Invest AB is a Sweden-based research and development company engaged in the measurement, collection and destruction of Nitrous Oxide (N2O). The Company works on process gas purification, gas measurement, ventilation, and control and specialized in catalytic gas purification. The Companyâs customers are mainly in healthcare areas that require a climate-smart use of Nitrous Oxide for pain relief such as Maternity wards, Childrenâs healthcare facilities and Dental care facilities.

Sector

Industrial Machinery & Equipment

Calendar

2024-08-20 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Testing & Measuring Equipment

	1st Jan change	Capi.
MEDCLAIR AB	-28.78%	9.23M
SMC CORPORATION	+7.33%	32.99B
COGNEX CORPORATION	+13.66%	8.15B
BADGER METER, INC.	+26.95%	5.76B
WUHAN GUIDE INFRARED CO., LTD.	-7.95%	3.97B
INFICON HOLDING AG	+15.92%	3.75B
RENISHAW PLC	+13.07%	3.7B
HORIBA, LTD.	+24.52%	3.54B
ESCO TECHNOLOGIES INC.	-8.31%	2.76B
BEIJING DAHAO TECHNOLOGY CORP.,LTD	+12.37%	2.29B

Testing & Measuring Equipment